Charles A. Baker, Director at REGENERON PHARMACEUTICALS INC (REGN), sold 3,000 shares at $390.67 ($1.2M) on 2016-12-12, disclosed to the SEC on 2016-12-14.
Open-market sale of $1.2M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $390.67 | 600 | $234K | 19.9% |
| 2 | $391.36 | 1,200 | $470K | 39.9% |
| 3 | $392.41 | 400 | $157K | 13.3% |
| 4 | $393.64 | 600 | $236K | 20.1% |
| 5 | $394.33 | 200 | $79K | 6.7% |
| Total | $392.02 avg | 3,000 |
| $1.2M |
| 100% |
| Filing → |
| REGN | SELL | 2015-03-26 | $2.3M | — | Filing → |
| REGN | SELL | 2014-03-25 | $4.5M | — | Filing → |
| REGN | SELL | 2013-10-02 | $4.7M | — | Filing → |